1Y Target$48.15Near-term target
5Y Target$71.75Compound horizon
10Y Target$186.69Long-dated conviction
FCF——FCF not applicable for this sector (bank / insurer / REIT) or data unavailable
Rev+98.0%TTM YoYARevenue +98.0% — hypergrowth, top decile
D/E0.07AD/E 0.07 — essentially debt-free, pristine balance sheet
P/S18.7xCP/S 18.7x — elevated; requires growth to justify
PEG——PEG not meaningful — earnings growth negative or data unavailable
Why now
Asset Management · market cap $14.3b. Down 35% from 52-week high of $54.94 — deep drawdown territory. Revenue growing +98% — in hypergrowth territory.
Moat
Net margin 33% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 28% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which.
Risk
Down 35% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. P/S 18.7x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard. Balance-sheet financial — book value, net interest margin, and credit loss provisions are the lever points; a rates regime change or a deterioration in the loan book moves the stock more than EPS does.
Horizon
1-3 yr $48.15 (structural (no analyst coverage)) — catalyst-driven; binary events dominate. 5 yr $71.75 — requires the platform / technology to reach commercial scale. 10 yr $186.69 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.